KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

Hypertension is a modifiable risk factor for cardiovascular morbidity and mortality and reduction of elevated blood pressure (BP) remains an important intervention for slowing kidney disease progression. Over the past decade, the most appropriate BP target for initiation and titration of BP-lowering...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Kidney Dis
Päätekijät: Kramer, Holly J., Townsend, Raymond R., Griffin, Karen, Flynn, Joseph T., Weiner, Daniel E., Rocco, Michael V., Choi, Michael J., Weir, Matthew R., Chang, Tara I., Agarwal, Rajiv, Beddhu, Srinivasan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6740329/
https://ncbi.nlm.nih.gov/pubmed/30905361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2019.01.007
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia